Abstract
This article reviews the literature for the most pressing diagnostic and treatment challenges faced in working with adolescents. Diagnosing the treatment interventions required for this population involve psychoeducation, engagement of the patient and family in the treatment process, and use of antipsychotic medications. Cannabis may be a causal risk factor in psychotic illness, and data support recommendations to reduce or cease cannabis use in this population. Treatment strategies are discussed that are effective in adult patients and that may be efficacious for youth to abstain from substances after the resolution of psychotic symptoms.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 643-654 |
| Number of pages | 12 |
| Journal | Child and adolescent psychiatric clinics of North America |
| Volume | 22 |
| Issue number | 4 |
| DOIs | |
| State | Published - Oct 2013 |
Bibliographical note
Funding Information:Disclosures: Dr Goerke, None; Dr Kumra has received research support from the Minnesota Medical Foundation , the National Alliance for Research on Schizophrenia and, Depression , and AstraZeneca .
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adolescent psychosis
- Cannabis and psychosis
- Dual diagnosis
- Substance-induced psychosis
Fingerprint
Dive into the research topics of 'Substance Abuse and Psychosis'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS